Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Sirkku Jyrkkiö"'
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Marginal zone lymphoma (MZL) is an indolent B-cell malignancy with heterogeneous anatomical and clinical presentation. While MZLs are generally associated with long survival, some patients experience histological transformation to aggressive
Externí odkaz:
https://doaj.org/article/b2a75e332a1c4313962dcc9cc3bae999
Autor:
Marja‐Liisa Huuskonen, Tero Koistinen, Niina Sihvola, Inkeri Parkkari, Sanna Palovaara, Ville Kytö, Jussi Sipilä, Sirkku Jyrkkiö, Eetu Heervä
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7406-7413 (2023)
Abstract Background Little controlled evidence exists on road traffic accident (RTA) risk among patients diagnosed with cancer, while clinicians are often requested to comment their ability to drive. The aim of this study was to evaluate RTA risk in
Externí odkaz:
https://doaj.org/article/600faf4c88f9473485cf964194d8fe4d
Autor:
Mikko S. Venäläinen, Eetu Heervä, Outi Hirvonen, Sohrab Saraei, Tomi Suomi, Toni Mikkola, Maarit Bärlund, Sirkku Jyrkkiö, Tarja Laitinen, Laura L. Elo
Publikováno v:
Cancer Medicine, Vol 11, Iss 3, Pp 654-663 (2022)
Abstract Background The existing risk prediction models for chemotherapy‐induced febrile neutropenia (FN) do not necessarily apply to real‐life patients in different healthcare systems and the external validation of these models are often lacking
Externí odkaz:
https://doaj.org/article/a4accec3641e4b499630a58b899048de
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-6 (2021)
Abstract Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare B-cell malignancy associated with excellent survival. However, some patients experience histological transformation into aggressive large B-cell lymphoma. Population-based dat
Externí odkaz:
https://doaj.org/article/7cdbd33b83c44b75b830291c76a2b6ec
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundSomatostatin receptors (SSTR) and chemokine receptor CXCR4 are expressed in lymphomas, while the abundance is known to be heterogeneous in different subtypes of lymphomas. Targeting tumor cells expressing these receptors might add to therap
Externí odkaz:
https://doaj.org/article/4bcfaac8a4ac45098a111bf7611e93fa
Autor:
Mehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, Outi Hirvonen, Sirkku Jyrkkiö, Laura L. Elo
Publikováno v:
F1000Research, Vol 5 (2019)
Metastatic castration resistant prostate cancer (mCRPC) is one of the most common cancers with a poor prognosis. To improve prognostic models of mCRPC, the Dialogue for Reverse Engineering Assessments and Methods (DREAM) Consortium organized a crowds
Externí odkaz:
https://doaj.org/article/91388e2532dd4391bc24954296a2e9a7
Autor:
Marja‐Liisa Huuskonen, Tero Koistinen, Niina Sihvola, Inkeri Parkkari, Sanna Palovaara, Ville Kytö, Jussi Sipilä, Sirkku Jyrkkiö, Eetu Heervä
Publikováno v:
Cancer Medicine. 12:7406-7413
Little controlled evidence exists on road traffic accident (RTA) risk among patients diagnosed with cancer, while clinicians are often requested to comment their ability to drive. The aim of this study was to evaluate RTA risk in a population-based c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd5e49e265e44749ed1ab27de1a655c7
https://doi.org/10.1002/cam4.5444
https://doi.org/10.1002/cam4.5444
Autor:
Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Maija Lepistö, Parisa Mapar, Yngvild Nuvin Blaker, Judit Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Idun Fiskvik, Lars Tore G. Mikalsen, Matias Autio, Magnus Björkholm, Mats Jerkeman, Øystein Fluge, Peter Brown, Sirkku Jyrkkiö, Harald Holte, Esa Pitkänen, Pekka Ellonen, Sirpa Leppä
Publikováno v:
Blood
Meriranta, L, Alkodsi, A, Pasanen, A, Lepistö, M, Mapar, P, Blaker, Y N, Jørgensen, J M, Karjalainen-Lindsberg, M-L, Fiskvik, I, Mikalsen, L T G, Autio, M, Björkholm, M, Jerkeman, M, Fluge, Ø, Brown, P, Jyrkkiö, S, Holte, H, Pitkänen, E, Ellonen, P & Leppa, S 2022, ' Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma ', Blood, vol. 139, no. 12, pp. 1863-1877 . https://doi.org/10.1182/blood.2021012852
Meriranta, L, Alkodsi, A, Pasanen, A, Lepistö, M, Mapar, P, Blaker, Y N, Jørgensen, J M, Karjalainen-Lindsberg, M-L, Fiskvik, I, Mikalsen, L T G, Autio, M, Björkholm, M, Jerkeman, M, Fluge, Ø, Brown, P, Jyrkkiö, S, Holte, H, Pitkänen, E, Ellonen, P & Leppa, S 2022, ' Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma ', Blood, vol. 139, no. 12, pp. 1863-1877 . https://doi.org/10.1182/blood.2021012852
Inadequate molecular and clinical stratification of the patients with high-risk diffuse large B-cell lymphoma (DLBCL) is a clinical challenge hampering the establishment of personalized therapeutic options. We studied the translational significance o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a8922736ebf9763275c471d8a04f16
https://doi.org/10.1182/blood.2021012852
https://doi.org/10.1182/blood.2021012852
Autor:
Samuli Tuominen, Kristiina Uusi-Rauva, Tea Blom, Sirkku Jyrkkiö, Kaisa Tuppurainen, Erika Alanne
Publikováno v:
Future Oncology. 18:1103-1114
Background: Real-world data on diffuse large B-cell lymphoma (DLBCL) has remained incomplete. In Finland, health record data originally recorded in different hospital data record systems are collectively available via data lake technology, enabling e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7756b87bacca974659d5d454cf196a60
https://doi.org/10.2217/fon-2021-0806
https://doi.org/10.2217/fon-2021-0806
Publikováno v:
Acta Oncologica. 60:106-111
Palliative care can reduce the symptom burden and may increase the life expectancy for patients with advanced malignancies. The aim of this study was to evaluate the impact of palliative intervention on the treatment procedures for pancreatic cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a15e7f19140b0ce793c4e7e5c1fc9f
https://doi.org/10.1080/0284186x.2020.1806356
https://doi.org/10.1080/0284186x.2020.1806356